万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
http://www.karger.com/Journal/Home/223832
3、投稿网址：
https://www.manuscriptmanager.net/CRD?product_id=223832
4、官网邮箱：crd@karger.com
5、官网电话：+41 61 306 1306
6、期刊刊期：月刊，一年出版十二期。
2021年5月25日星期二
投稿须知【官网信息】
Cardiology
Author Guidelines
About the Journal
Aims and Scope
Established in 1937, Cardiology provides a forum for scientific progress in the prevention, recognition, and treatment of heart disease. Bridging clinical, preclinical, and translational research, the contents include original research articles, topical reviews, and expert opinion commentaries. Sections such as “Coronary Artery Disease”, “Imaging”, “Electrophysiology and Arrhythmia”, or “eCardiology/Digital Health” highlight the wide variety of subspecialty areas covered and feature new developments in noninvasive and invasive diagnostic methods, epidemiology, as well as pharmacological, preventive, and mechanical/surgical therapies.
Cardiology publishes articles relevant to cardiologists, cardiac surgeons, internists, clinical physiologists, pharmacologists, and professionals from other areas of medicine interested in cardiovascular diseases.
Journal Sections
•Coronary Artery Disease and Acute Myocardial Infarction
•Cardiovascular Biomarkers
•Heart Failure and Intensive Care
•Cardiovascular Imaging
•Electrophysiology and Arrhythmia
•Cardiovascular Prevention
•Thrombocardiology
•Valvular Heart Disease
•Congenital Heart Disease
•Atrial Fibrillation and Stroke
•Sports Cardiology
•Cellular and Molecular Cardiology
•Cardiac Surgery
•Pulmonary Circulation and Right Ventricle
•eCardiology/Digital Health
•Icons in Cardiology
Article Types
Research Article
Research Articles report on primary research. They must describe significant and original observations. Consideration for publication is based on the article’s originality, novelty, and scientific soundness, and the appropriateness of its analysis.
Research Articles are reports of original work. Authors are asked to follow the EQUATOR Network for Research Articles.
Prior approval from an Institutional Review Board (IRB) or an Ethics Review Committee is required for all investigations involving human subjects.
A downloadable template is available below.
Documents
Research Article (DOCX, 28.97 KB)
Review Article
Review Articles are considered reviews of research or summary articles. They are state-of-the-art papers covering a current topic by experts in the field. They should give evidence on and provide answers to a well-defined aspect or question in a particular area. Review Articles must include a critical discussion of the reported data and give a clear conclusion with potential impacts on the standard of care.
A downloadable template is available below.
Documents
Review Article (DOCX, 23.66 KB)
Authors may wish to submit one of the following Review Articles:
Standard Review Article: Review articles should contain up to 4,500 words and 50 references.
Turning Basic Research into Clinical Success: One or two focused review articles are published in each issue and should offer an overview of existing translational concepts and literature in a format understandable to the largely clinical cardiologist readership, i.e. with limited sophistication as to methods and terminology from cellular and molecular biology. Most manuscripts are submitted upon invitation. Authors planning to submit an unsolicited paper are requested to contact the Editorial Office with an outline of the intended contribution. All submissions are subject to peer review. These articles are available also to nonsubscribers in free access on the journal's website.
Systematic Review
Systematic Reviews are literature reviews focused on a research question that synthesizes all high-quality research evidence relevant to that question. Systematic Reviews should be presented in the Introduction, Methods, Results, Discussion format. The subject must be clearly defined. The objective of a Systematic Review should be to arrive at an evidence-based conclusion. The Methods section should give a clear indication of the literature search strategy, data extraction procedure, grading of evidence, and kind of analysis used. We strongly encourage authors to comply with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
A downloadable template is available below.
Documents
Systematic Review (DOCX, 27.56 KB)
Brief Report
Brief Reports are short and/or rapid announcements of research results. They must contain data derived from cutting-edge research and be of potential interest to a large proportion of the readership. They are independent, concise reports representing a significant contribution to the field. Such communications should represent complete, original studies and should be arranged in the same way as full-length manuscripts with subheadings.
A downloadable template is available below.
Documents
Brief Report (DOCX, 27.12 KB)
Authors may wish to submit the following type of Brief Report:
Short Communications: Short Communications are brief announcements of results from cutting-edge research. They are independent, concise reports representing a significant contribution to the field. These manuscripts should not contain more than 2,000 words, including key words, essential references (not more than 15) and not more than 3 tables or figures. Such communications should represent complete, original studies and should be arranged in the same way as full length manuscripts.
Commentary
Commentaries draw attention to a jointly published article, discussing the context or implications of the article and highlighting points of wider relevance to the field. Commentaries are presented from the author’s perspective and do not include original data. Commentaries are invited by the Editors and relate to an article in the same issue.
Commentaries should not exceed 1'000 words plus up to 5 references.
A downloadable template is available below.
Documents
Commentary (DOCX, 23.56 KB)
Please note we allow the following type of Commentaries:
Editorial Comments: Commentaries are invited by the Editors and relate to an article in the same issue. The word limit is 1'500 words plus up to 12 references.
Editorial
Editorials provide a viewpoint on specific articles or on general subjects directly relevant to the journal. Editorials are written by an editor or other member of the journal.
Editorials should not exceed 500 words
A downloadable template is available below.
Documents
Editorial (DOCX, 24.95 KB)
Only upon invitation!
Letter
Letters may explore subjects related to matters discussed in the journal, providing the author’s perspective on a subject. Letters may discuss a recently published article and may lend support or constructively critique the article in line with the author’s experience. The editors reserve the right to share such letters to the authors of the article concerned prior to publication in order to permit response, ideally in the same issue of the journal. Letters should not include original data.
Letters should not exceed 2000 words and have a maximum 15 references & 1 figure/table
A downloadable template is available below.
Documents
Letter (DOCX, 24.24 KB)
Letters should contain up to 1,500 words, including references.
The Section 'Icons in Cardiology' is by invitation only.
Methods Article
Methods Articles primarily describe methods or procedures used to perform an experiment or research rather than report the results of the research.
A downloadable template is available below.
Documents
Method Article (DOCX, 24.33 KB)
Authors may wish to submit the following type of Methods Article:
Clinical Trial Design: Method articles will be accepted reporting the study design protocols of planned clinical trials that have been appropriately registered with regulatory authorities, and which carry the potential of practice-changing outcomes. Methods articles should contain up to 4,500 words and 35 references.
Contact Information
Should you have any problems with your submission, please contact the editorial office:
Karin Fava
Editorial Office 'CARDIOLOGY'
S. Karger AG
P.O. Box
CH-4009 Basel (Switzerland)
Tel. +41 61 306 1306
Fax +41 61 306 1434
crd@karger.com
Editorial and Journal Policies
General Conditions
Only papers written in English are considered. The articles should be comprehensible to a reader who is fluent in English and should be edited prior to submission to ensure that standard English grammar and usage are observed. Use of a professional language editing service prior to submission can help avoid delays with the review process.
All manuscripts are subject to editorial review.
The presentation of manuscripts should follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals from the International Committee of Medical Journal Editors (ICMJE).
Karger journals aim to adhere to the COPE Code of Conduct and Best Practice Guidelines.
By submitting an article for publication, the authors agree to the transfer of the copyright to the publisher upon acceptance. Accepted papers become the permanent property of the Journal and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.
The Submission Statement with original (hand-written) signatures is to be provided upon submitting the paper. If it is not possible to collect all signatures on a single document, individual copies should be provided for each author.
Karger recommends the use of original images and materials whenever possible. If a submitted manuscript contains third-party copyright material(s), it is the authors’ sole responsibility to obtain permission from the relevant copyright holder for reusing the material(s), including any associated licensing fee. The copyright and usage information needs to be checked carefully to avoid copyright infringement.
Most publishers offer a quick and easy way to clear permissions for their content via the built-in website application RightsLink or via https://www.copyright.com/get-permissions/. Another widely used licensing tool is PLSClear. Please check the publishers’ websites for the available options and user instructions.
Statements
All submitted manuscripts must contain a Statement of Ethics, a Conflict of Interest Statement, an Author Contributions Statement and a Data Availability Statement after the main body of the text, but before the reference list.
Statement of Ethics
Published research must comply with internationally-accepted standards for research practice and reporting. Manuscripts may be rejected if the editors believe that the research has not been carried out within an appropriate ethical framework, and concerns raised after publication may lead to a correction, retraction, or expression of concern in line with COPE guidelines.
Studies involving human subjects (including research on identifiable human material and data) must have been performed with the approval of an appropriate ethics committee and with appropriate participants’ informed consent in compliance with the Helsinki Declaration.
In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate. If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision).
For all research involving human subjects, written informed consent to participate in the study should be obtained from participants (or their parent/legal guardian where appropriate ) and a statement detailing this should appear in the manuscript. For studies involving vulnerable participants or participants at risk of potential coercion, detailed information regarding the steps taken to ensure informed consent must be provided. If consent was not obtained, please specify why and whether this was approved by the ethics committee.
In line with the ICMJE recommendations on the protection of research participants, authors must avoid providing identifying information unless strictly necessary for the submission and participants’ identifiable attributes must be anonymized in the manuscript and its supplementary files, if any. If identifying information is necessary, authors must confirm that the individual has provided written consent for the use of that information in a publication.
Research involving human embryonic stem cells, embryonic germ cells or induced pluripotent stem cells should comply with the ISSCR 'Guidelines for the Conduct of Human Embryonic Stem Cell Research' or an equivalent set of guidelines or applicable regulations.
Case Reports: Manuscripts reporting a case report must include a statement detailing that written informed consent for publication was obtained and from whom (e.g. “Written informed consent was obtained from the patient for publication of this case report and any accompanying images.”). If the patient has died, consent for publication must be obtained from their next of kin. If the patient described in the case report is a minor or vulnerable, then consent for publication must be obtained from the parent/legal guardian. The completed consent form must be made available to the Editor if requested, and will be treated confidentially.
Clinical Trials: In accordance with the ICMJE recommendations, all clinical trials should be registered in a publicly available registry approved by the WHO or ICMJE (see the list here) and the clinical trial number must be clearly stated in the manuscript. Manuscripts reporting clinical trials must adhere to the relevant reporting guidelines for their study design, such as CONSORT for randomized controlled trials, TREND for non-randomized trials, or other relevant reporting guidelines as detailed on the Equator network website.
Karger follows the WHO definition of clinical trials "A clinical trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes [...] Interventions include but are not restricted to drugs, cells and other biological products, surgical procedures, radiologic procedures, devices, behavioural treatments, process-of-care changes, preventive care, etc. This definition includes Phase I to Phase IV trials.”
Studies involving animals: Experimental research on vertebrates or any regulated invertebrates must have been approved by the authors' Institutional Animal Care and Use Committee (IACUC) or equivalent ethics committee and must follow internationally recognized guidelines such as the ARRIVE guidelines. In the manuscript, authors should specify the name of the ethics committee or other relevant authority who approved the study protocol and provide the reference number where appropriate.
If ethics approval was not required, or if the study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee who made that decision). Additional information is expected for studies reporting death of a regulated animal as a likely outcome or planned endpoint. Other types of studies including field studies and non-experimental research on animals must comply with local or international guidelines, and where appropriate must have been approved by an appropriate ethics committee.
……
更多详情：
https://www.karger.com/Journal/Guidelines/223832
